Product Information

IBANDRONATE SODIUM 150 MG TAB is a generic product labeled by Aurobindo Pharma Limited, priced at $2.7524 per EA under NDC 65862023703. Its NADAC has been published 502 times since Jan 11, 2017.

FDA first approved this application on Mar 11, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

IBANDRONATE SODIUM 150 MG TAB

Ibandronate Sodium
$2.7524per EA

Strength

150 mg/1

NDC

65862023703

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

IBANDRONATE SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA204502

FDA Approved

3/11/2016

TE Code

AB

On Market Since

3/11/2016

Pharmacological Classes

Bisphosphonate
Diphosphonates

Price Statistics

The NADAC for IBANDRONATE SODIUM 150 MG TAB has been published 502 times since Jan 11, 2017, and over the history we have for it it has declined 82.4%. The table below summarizes its recorded NADAC range and movement.

Current price$2.7524 per EA
All-time high$15.6377 (Jan 11, 2017)
All-time low$2.7262 (Nov 20, 2024)
52-week high$3.3363
52-week low$2.7524
Median price$5.5433
Average price$5.8637
Largest weekly change-37.5% (Nov 20, 2024)
Weeks tracked502
Tracking sinceJan 11, 2017

Price History

1W

-0.2%

1M

-0.2%

3M

-2.0%

6M

-3.1%

1Y

-17.5%

3Y

-31.2%

5Y

-54.5%

All

-82.4%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Ibandronate Sodium market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of IBANDRONATE SODIUM 150 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for IBANDRONATE SODIUM 150 MG TAB, manufactured by Aurobindo Pharma Limited, is $2.7524 per EA (NDC 65862023703), effective Aug 19, 2026.

How has the price of IBANDRONATE SODIUM 150 MG TAB changed over time?

Over the history we have for it, the NADAC for IBANDRONATE SODIUM 150 MG TAB has declined 82.4%. It has been tracked across 502 weekly CMS publications since Jan 11, 2017.

What are the highest and lowest recorded NADAC prices for IBANDRONATE SODIUM 150 MG TAB?

Since Jan 11, 2017, the NADAC for IBANDRONATE SODIUM 150 MG TAB has ranged from a low of $2.7262 (Nov 20, 2024) to a high of $15.6377 (Jan 11, 2017), with a median of $5.5433 per EA.

Are there cheaper alternatives to IBANDRONATE SODIUM 150 MG TAB?

No other NADAC-published product currently shares the active ingredient and strength of IBANDRONATE SODIUM 150 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures IBANDRONATE SODIUM 150 MG TAB?

IBANDRONATE SODIUM 150 MG TAB (NDC 65862023703) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.